ZiBiPen

Engineering Allergic Reaction Preparedness

Impulse Biomedical’s ZiBiPen is a versatile reloadable Emergency Auto Injector platform, with our launch model developed specifically for the treatment of anaphylaxis with adrenaline. This user-friendly, life-saving device provides a swift and efficient response, buying crucial time until medical help can be reached.

ZiBiPen

Engineering Allergic Reaction Preparedness

Impulse Biomedical’s ZiBiPen is a versatile reloadable Emergency Auto Injector platform, with our launch model developed specifically for the treatment of anaphylaxis with adrenaline. This user-friendly, life-saving device provides a swift and efficient response, buying crucial time until medical help can be reached.

Life-Threatening Allergies

Experiencing an allergic reaction can be an intense and frightening ordeal. Individuals who suffer from severe allergies face grave repercussions when exposed to allergens to which they have developed heightened sensitivity. They are triggered by specific factors such as allergens or underlying physiological imbalances.

In each case, the body’s immune or physiological response to these triggers can lead to a rapid and intense cascade of symptoms, necessitating immediate intervention and treatment with an auto-injector. The auto-injector serves as a vital tool to deliver precise doses of medication quickly and efficiently, helping to counteract the adverse effects of these conditions and potentially save lives.

Life-Threatening Allergies

Experiencing an allergic reaction can be an intense and frightening ordeal. Individuals who suffer from severe allergies face grave repercussions when exposed to allergens to which they have developed heightened sensitivity. They are triggered by specific factors such as allergens or underlying physiological imbalances.

In each case, the body’s immune or physiological response to these triggers can lead to a rapid and intense cascade of symptoms, necessitating immediate intervention and treatment with an auto-injector. The auto-injector serves as a vital tool to deliver precise doses of medication quickly and efficiently, helping to counteract the adverse effects of these conditions and potentially save lives.

Reloading Healthcare

With its unique reloadable cartridges, the ZiBiPen is poised to make a significant impact on the healthcare industry. This modular innovation ensures that patients don’t have to purchase a new autoinjector every time their medication runs out or expires, reducing cost and waste, while improving access and patient compliance.

Bridging the Critical Gap

By empowering individuals to quickly administer treatment during severe allergic reactions, ZiBiPen bridges the critical gap between symptom onset and professional medical assistance. This device not only saves lives but also mitigates the risk of delayed treatment, reducing the potential for long-term complications and healthcare costs.

Bridging the Critical Gap

By empowering individuals to quickly administer treatment during severe allergic reactions, ZiBiPen bridges the critical gap between symptom onset and professional medical assistance. This device not only saves lives but also mitigates the risk of delayed treatment, reducing the potential for long-term complications and healthcare costs.

Commercial Future

Meaningful Impact

With a vision to make a meaningful impact on the lives of millions affected by allergies and anaphylaxis worldwide, our scaling plan involves global expansion of ZiBiPen.

Engineer

As a versatile Emergency Auto Injector platform, ZiBiPen positions itself to extend its reach into diverse therapeutic areas, amplifying its potential to serve a broader range of patients in need.

Right Support

Multiple investors and partners have supported the development and commercialisation of ZiBiPen, giving them the opportunity to contribute to the improvement of patient care, address unmet medical needs, and tap into a growing market for advanced emergency medical devices.

Join our dynamic network of collaborators, followers, endorsers and partners.